- Home
- TNGX vs NBBK Comparison
TNGX vs NBBK Comparison
Compare TNGX & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- NBBK
- Stock Information
- Founded
- TNGX 2014
- NBBK 1892
- Country
- TNGX United States
- NBBK United States
- Employees
- TNGX N/A
- NBBK N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- NBBK
- Sector
- TNGX Health Care
- NBBK
- Exchange
- TNGX Nasdaq
- NBBK Nasdaq
- Market Cap
- TNGX 723.2M
- NBBK 722.1M
- IPO Year
- TNGX N/A
- NBBK N/A
- Fundamental
- Price
- TNGX $7.58
- NBBK $18.00
- Analyst Decision
- TNGX Strong Buy
- NBBK Buy
- Analyst Count
- TNGX 6
- NBBK 1
- Target Price
- TNGX $10.00
- NBBK $20.00
- AVG Volume (30 Days)
- TNGX 2.6M
- NBBK 155.3K
- Earning Date
- TNGX 11-05-2025
- NBBK 10-29-2025
- Dividend Yield
- TNGX N/A
- NBBK 1.57%
- EPS Growth
- TNGX N/A
- NBBK 341.36
- EPS
- TNGX N/A
- NBBK 1.33
- Revenue
- TNGX $24,296,000.00
- NBBK $179,117,000.00
- Revenue This Year
- TNGX $20.42
- NBBK N/A
- Revenue Next Year
- TNGX N/A
- NBBK N/A
- P/E Ratio
- TNGX N/A
- NBBK $13.43
- Revenue Growth
- TNGX N/A
- NBBK 28.24
- 52 Week Low
- TNGX $1.03
- NBBK $15.09
- 52 Week High
- TNGX $8.80
- NBBK $21.05
- Technical
- Relative Strength Index (RSI)
- TNGX 51.87
- NBBK 46.22
- Support Level
- TNGX $7.66
- NBBK $17.40
- Resistance Level
- TNGX $8.80
- NBBK $18.38
- Average True Range (ATR)
- TNGX 0.51
- NBBK 0.41
- MACD
- TNGX -0.04
- NBBK -0.07
- Stochastic Oscillator
- TNGX 33.70
- NBBK 39.39
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About NBBK NB Bancorp Inc.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.